The company is redefining their use through a science-driven selection process and a proprietary method to identify biological functions. 

We introduce a new standard of economic efficiency in bioactive peptides, with 97% of Proteimax candidates advancing from lab to animal validation. 

With deep scientific insights and our proprietary functional screening platform, our team is driving a fundamental shift in how peptide candidates are discovered and validated, achieving very high success rates and a significantly  faster development time-to-value.